Literature DB >> 10951423

Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.

E Topuz1, Y Salihoglu, A Aydiner, P Saip, F Tas, T Sozen, S Berkman, E Bengisu.   

Abstract

BACKGROUND AND OBJECTIVES: In ovarian cancer, development of safe and effective methods for providing long-term access to the peritoneal cavity has become increasingly important.
METHODS: A modified Port-A-Cath (Celsite-port and catheters, B. Braun, Chasseneuil, France) was used in 56 patients with presumed epithelial ovarian cancer at the conclusion of primary or second-look laparotomy. In 37 patients, ports were located on the right costal margin in the midclavicular region and in 19 in the xiphoid region.
RESULTS: In 56 catheters, 8 (13.8%) complications of severe or moderate degree during the treatment were registered. In-flow obstruction of device occurred in 6 patients, and there was 1 viscous perforation and 1 catheter related infectious peritonitis. Grade III-IV pain and in-flow obstruction were developed in the patients with ports implanted on the right costal margin but not with ports implanted in the xiphoid region.
CONCLUSION: The complication rate of intraperitoneal access devices is comparatively low.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951423     DOI: 10.1002/1096-9098(200007)74:3<223::aid-jso14>3.0.co;2-q

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Percutaneous placement of peritoneal port-catheter in oncologic patients.

Authors:  Franco Orsi; Paolo Della Vigna; Silvia Penco; Guido Bonomo; Elena Lovati; Massimo Bellomi
Journal:  Eur Radiol       Date:  2004-06-18       Impact factor: 5.315

2.  Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis.

Authors:  Zhongyin Yang; Chen Li; Wentao Liu; Yanan Zheng; Zhenglun Zhu; Zichen Hua; Zhentian Ni; Sheng Lu; Min Yan; Chao Yan; Zhenggang Zhu
Journal:  Chin J Cancer Res       Date:  2020-08       Impact factor: 5.087

3.  Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial.

Authors:  Nadine Leonie de Boer; Alexandra R M Brandt-Kerkhof; Eva V E Madsen; Marjolein Diepeveen; Esther van Meerten; Ruben A G van Eerden; Femke M de Man; Rachida Bouamar; Stijn L W Koolen; Ignace H J T de Hingh; Checca Bakkers; Koen P Rovers; Geert-Jan M Creemers; Maarten J Deenen; Onno W Kranenburg; Alexander Constantinides; Ron H J Mathijssen; Cornelis Verhoef; Jacobus W A Burger
Journal:  BMJ Open       Date:  2019-12-08       Impact factor: 2.692

4.  Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.

Authors:  Jun Kinoshita; Sachio Fushida; Tomoya Tsukada; Katsunobu Oyama; Toshifumi Watanabe; Koichi Okamoto; Isamu Makino; Keishi Nakamura; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hidehiro Tajima; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Takashi Fujimura; Tetsuo Ohta
Journal:  World J Surg Oncol       Date:  2014-06-04       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.